Regular preventive treatment with the approved infusion therapy Adzynma (ADAMTS13 recombinant-krhn)Â may help reduce the long-term risk of organ damage…
Articles by Michela Luciano, PhD
A South Korean study found that people with immune thrombocytopenia (ITP) who received thrombopoietin receptor agonists (TPO-RAs) as second-line…
The final results of a now-completed global clinical trial have confirmed that the approved infusion therapy Adzynma (ADAMTS13 recombinant-krhn) prevents…
Longer treatment with Wayrilz (rilzabrutinib) helped raise and maintain platelet counts in adults with immune thrombocytopenia (ITP), including…
In a clinical trial involving adults with hard-to-treat immune thrombocytopenia (ITP), adding a 12-week course of a vitamin A-derived…
A three-week educational program delivered through WhatsApp may help mothers of children with immune thrombocytopenia (ITP) prevent Helicobacter pylori…
Researchers in Turkey have uncovered changes in immune cells and surface proteins on platelets, which are tiny, colorless cell fragments…
An elderly man initially thought to have primary immune thrombocytopenia (ITP), which occurs without an identifiable underlying cause, was…
Treatment with all-trans retinoic acid (ATRA), a compound derived from vitamin A, may help restore production of clot-promoting platelets in…
The lack of a key enzyme in thrombotic thrombocytopenic purpura (TTP) may threaten fetal survival during pregnancy, according to…